Results 171 to 180 of about 1,844 (180)
Some of the next articles are maybe not open access.
Reflections on community experience with Mavacamten
Progress in Cardiovascular DiseasesClement, Eiswirth, Yvonne E, Gilliland
openaire +2 more sources
A Collaborative Approach to Mavacamten Care: A Pharmacist-Nurse Led Mavacamten Monitoring Program
Heart, Lung and CirculationV. Warner +11 more
openaire +1 more source
Stop Dreaming: Mavacamten REMS Data Are Here
Circulation: Heart FailureAhmad Masri, Neal K. Lakdawala
openaire +2 more sources
Mavacamten (Camzyos) for obstructive hypertrophic cardiomyopathy.
The Medical letter on drugs and therapeutics, 2022openaire +1 more source
Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic Cardiomyopathy
Mayo Clinic ProceedingsJohn R, Giudicessi +7 more
openaire +2 more sources
Mavacamten (â–¼Camzyos) for obstructive hypertrophic cardiomyopathy
Drug and Therapeutics Bulletinopenaire +1 more source
PLN-related obstructive hypertrophic cardiomyopathy responsive to mavacamten
European Heart JournalMatteo Beltrami +2 more
openaire +2 more sources
Mavacamten - Erster Wirkstoff gegen obstruktive hypertrophe Kardiomyopathie
Österreichische Apothekerzeitung, 2023openaire +1 more source